A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine†

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 4, 2015-07 ,pp. : 327-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brain-derived Neurotrophic Factor Genetic Variants are Associated with Major Depression Susceptibility and Serotonin Reuptake Inhibitor Antidepressant Treatment Response in Taiwanese

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 4, 2013-12 ,pp. : 316-323

Bentham Science Publishers

Access to resources Recommend Favorite

Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy: Following Selective Serotonin Reuptake Inhibitor Therapy for Depression

By Griffiths R.I.  

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 495-505

Adis International

Access to resources Recommend Favorite

Dopamine receptor binding in major depression: changes before and after treatment with selective serotonin reuptake inhibitors

By Klimke A.   Larisch R.   Janz A.   Vosberg H.   Muuml ller-Gauml rtner H.W.   Gaebel W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 300-300

Elsevier

Access to resources Recommend Favorite

Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing

By Inoue T.   Hashimoto S.   Tsuchiya K.   Izumi T.   Ohmori T.   Koyama T.  

European Journal of Pharmacology, Vol. 311, Iss. 1, 1996-09 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite